Research ArticleMetabolic Disease

Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes

See allHide authors and affiliations

Science Translational Medicine  23 Dec 2015:
Vol. 7, Issue 319, pp. 319ra205
DOI: 10.1126/scitranslmed.aac6336

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article